Baird lowered the firm’s price target on Apellis (APLS) to $55 from $92 and keeps an Outperform rating on the shares. The firm said they reported 3Q24 results, including a sequentially lower Syfovre revenue quarter on modest vial growth but lower net price and increased competition.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLS: